Karyopharm Therapeutics Stock News

Karyopharm Therapeutics Inc (NASDAQ: KPTI) stock plunged after an update on its supplemental New Drug Application submission based on the Phase 3 SIENDO study data of selinexor as front-line mainte

Gainers: SoFi Technologies SOFI +20%. Scientific Games Corp SGMS +10%

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) has a beta value of -0.35 and has seen 15.31 million shares traded in the last trading session. The company, currently valued at $650.43M, closed the last trade at $10.29 per share which meant it lost -$4.09 on the day or -28.44% during that session. The KPTI stock price is -49.66% Karyopharm Therapeutics Inc. (KPTI) Shares Are Down -29.47% So Far This Year Read More »

Karyopharm Therapeutics Inc (NASDAQ: KPTI) revealed that executive vice president and chief medical officer Jatin Shah departs for "other professional opportunities." While CEO Paulson looks for Shah

Karyopharm Therapeutics Inc (NASDAQ: KPTI ) revealed that executive vice president and chief medical officer Jatin Shah departs for "other professional opportunities." While CEO Paulson looks for Shah''s replacement, he has recruited two Big Pharma vets to take up key posts on the team: Full story available on Benzinga.com

Investors aren't pleased with the surprise departure of the company's chief medical officer.

Investors aren''t pleased with the surprise departure of the company''s chief medical officer.

Investors aren't pleased with the surprise departure of the company's chief medical officer.

Karyopharm Therapeutics (KPTI) has lost ~24% in the pre-market Tuesday after the company announced that its Executive Vice President and Chief Medical Officer Jatin Shah had decided to

Gainers Sky Harbour Group Corporation (NYSE: SKYH ) shares jumped 48.4% to close at $10.09 on Friday. RISE Education Cayman Ltd (NASDAQ: REDU ) gained 39.7% to settle at $0.95. RISE Education Cayman recently entered into a definitive merger agreement with Dada Auto Inc. HOOKIPA Pharma Inc. (NASDAQ: HOOK ) surged 24% to close at $2.48. HOOKIPA Pharma recently entered into an amended and restated collaboration and license agreement with Gilead to develop immunotherapies against HIV. Universal Security Instruments, Inc. (NYSE: UUU ) jumped 23.8% to settle at $2.99. Universal Security Instruments recently said Q3 EPS results were lower year over year. Amplitude, Inc. (NASDAQ: AMPL ) gained 20.8% to close at $20.66. Amplitude recently reported Q4 earnings results and issued Q1 and FY22 sales guidance below estimates. Maris-Tech Ltd. (NASDAQ: MTEK ) climbed 20.7% to close at $2.27. Maris-Tech reported plans to co-develop video-based advanced AI systems for drones and autonomous vehicles. Cyngn Inc. (NASDAQ: CYN ) gained 20% to close at $1.74.

Primary endpoint of phase 3 SIENDO study met in which a statistically significant improvement of progression-free survival was observed in patients treated with selinexor over placebo.

Gainers: HOOKIPA Pharma (HOOK) +26%.Maris-Tech (MTEK) +18%.Karyopharm Therapeutics (KPTI) +18%.Creative Medical Technology Holdings (CELZ) +15%.Cambium Networks (CMBM) +16%.Inotiv…

NEW YORK , Feb. 18, 2022 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for CELZ, NU, GOLD, OPEN, and KPTI. … Full story available on Benzinga.com

Karyopharm <> shares surged on Friday on the news that the company had canceled its participation at the Annual SVB Leerink Global Healthcare Conference.Last week, the…